Patents by Inventor Krystyna Wozniak

Krystyna Wozniak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Administering Water-Soluble Prodrugs of Propofol
    Publication number: 20080214508
    Abstract: A method of administering a prodrug of propofol, preferably O-phosphonooxymethyl propofol disodium salt, comprises the subcutaneous or rectal administration of the prodrug in amounts sufficient to induce or maintain a generalized anesthetized state, a conscious sedated state, or to treat insomnia, anxiety, nausea, vomiting, pruritus, epilepsy, and a range of pain syndromes, including migraine pain, and other medical conditions.
    Type: Application
    Filed: September 14, 2005
    Publication date: September 4, 2008
    Applicant: MGI GP, INC.
    Inventors: Barbara S. Slusher, Krystyna Wozniak
  • Methods Of Administering Water-Soluble Prodrugs Of Propofol For Extended Sedation
    Publication number: 20070202158
    Abstract: A method of administering a prodrug of propofol, preferably O-phosphonooxymethyl propofol disodium salt, comprises the oral, intragastric, or intraintestinal administration of the prodrug in amounts sufficient to induce or maintain a generalized anesthetized state, a conscious sedated state, or to treat insomnia, anxiety, nausea, vomiting, pruritus, epilepsy, and a range of pain syndromes and other medical conditions.
    Type: Application
    Filed: December 17, 2004
    Publication date: August 30, 2007
    Applicant: MGI GP, Inc.
    Inventors: Barbara Slusher, Krystyna Wozniak
  • Naaladase inhibitors for treating retinal disorders and glaucoma
    Patent number: 7220780
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating a retinal disorder or glaucoma using NAALADase inhibitors.
    Type: Grant
    Filed: May 30, 2001
    Date of Patent: May 22, 2007
    Assignee: Guilford Pharmaceuticals Inc.
    Inventors: Barbara S. Slusher, Krystyna Wozniak
  • Naaladase inhibitors for treating huntington's disease
    Publication number: 20050080139
    Abstract: This invention relates to a pharmaceutical composition and a method for treating Huntington's disease using NAAL-ADase inhibitors.
    Type: Application
    Filed: December 27, 2002
    Publication date: April 14, 2005
    Inventors: Barbara Slusher, Krystyna Wozniak
  • Methods for treating certain diseases using naaladase inhibitors
    Patent number: 6806261
    Abstract: The present invention relates to methods for regulating the release of TGF-&bgr; from living cells in vitro or in vivo, comprising bringing the cells into contact with an effective amount of a NAALADase inhibitor. Such methods are believed to be useful for affecting neuroregeneration, cell proliferation, cell differentiation, extracellular matrix formation, myelination, inflammation, immune function, liver function, pancreatic function, angiogenesis, or wound healing; and/or for preventing or treating diabetes.
    Type: Grant
    Filed: August 1, 2002
    Date of Patent: October 19, 2004
    Assignee: Guilford Pharmaceuticals Inc.
    Inventors: Barbara S. Slusher, Xi-Chun May Lu, Krystyna Wozniak
  • Naaladase inhibitors for treating opioid tolerance
    Publication number: 20040186081
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating opioid tolerance using NAALADase inhibitors.
    Type: Application
    Filed: March 3, 2004
    Publication date: September 23, 2004
    Applicant: Guilford Pharmaceuticals Inc.
    Inventors: Barbara S. Slusher, Krystyna Wozniak
  • Naaladase inhibitors for treating retinal disorders and glaucoma
    Publication number: 20030036534
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating a retinal disorder or glaucoma using NAALADase inhibitors.
    Type: Application
    Filed: May 30, 2001
    Publication date: February 20, 2003
    Inventors: Barbara S. Slusher, Krystyna Wozniak
  • Methods for treating certain diseases using naaladase inhibitors
    Publication number: 20030017965
    Abstract: A method for regulating the release of TGF-&bgr; from living cells in vitro or in vivo, comprising bringing the cells into contact with an effective amount of a NAALADase inhibitor. Such methods are believed to useful for affecting neuroregeneration, cell proliferation, cell differentiation, extracellular matrix formation, myelination, inflammation, immune function, liver function, pancreatic function, angiogenesis, or wound healing; and/or preventing or treating diabetes.
    Type: Application
    Filed: August 1, 2002
    Publication date: January 23, 2003
    Inventors: Barbara S. Slusher, Xi-Chun May Lu, Krystyna Wozniak
  • Methods for treating certain diseases using naaladase inhibitors
    Patent number: 6444657
    Abstract: The present invention relates to methods of using NAALADase inhibitors to regulate TGF-&bgr; and to treat neurodegenerative disorders, extracellular matrix formation disorders, cell-growth related diseases, infectious diseases, immune related diseases, epithelial tissue scarring, collagen vascular diseases, fibroproliferative disorders, connective tissue disorders, inflammatory diseases, respiratory distress syndrome and infertility.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: September 3, 2002
    Assignee: Guilford Pharmaceuticals Inc.
    Inventors: Barbara S. Slusher, Xi-Chun May Lu, Krystyna Wozniak
  • Naaladase inhibitors for treating amyotrophic lateral sclerosis
    Publication number: 20020013295
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating amyotrophic lateral sclerosis using NAALADase inhibitors.
    Type: Application
    Filed: May 30, 2001
    Publication date: January 31, 2002
    Inventors: Barbara S. Slusher, Krystyna Wozniak